Global Remicade Biosimilar Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Remicade Biosimilar Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Remicade Biosimilar by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Remicade Biosimilar by Country/Region, 2017, 2022 & 2028

2.2 Remicade Biosimilar Segment by Type

2.2.1 100mg/10ml

2.2.2 500mg/50ml

2.3 Remicade Biosimilar Sales by Type

2.3.1 Global Remicade Biosimilar Sales Market Share by Type (2017-2022)

2.3.2 Global Remicade Biosimilar Revenue and Market Share by Type (2017-2022)

2.3.3 Global Remicade Biosimilar Sale Price by Type (2017-2022)

2.4 Remicade Biosimilar Segment by Application

2.4.1 Blood Disorders

2.4.2 Oncology Diseases

2.5 Remicade Biosimilar Sales by Application

2.5.1 Global Remicade Biosimilar Sale Market Share by Application (2017-2022)

2.5.2 Global Remicade Biosimilar Revenue and Market Share by Application (2017-2022)

2.5.3 Global Remicade Biosimilar Sale Price by Application (2017-2022)

3 Global Remicade Biosimilar by Company

3.1 Global Remicade Biosimilar Breakdown Data by Company

3.1.1 Global Remicade Biosimilar Annual Sales by Company (2020-2022)

3.1.2 Global Remicade Biosimilar Sales Market Share by Company (2020-2022)

3.2 Global Remicade Biosimilar Annual Revenue by Company (2020-2022)

3.2.1 Global Remicade Biosimilar Revenue by Company (2020-2022)

3.2.2 Global Remicade Biosimilar Revenue Market Share by Company (2020-2022)

3.3 Global Remicade Biosimilar Sale Price by Company

3.4 Key Manufacturers Remicade Biosimilar Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Remicade Biosimilar Product Location Distribution

3.4.2 Players Remicade Biosimilar Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Remicade Biosimilar by Geographic Region

4.1 World Historic Remicade Biosimilar Market Size by Geographic Region (2017-2022)

4.1.1 Global Remicade Biosimilar Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Remicade Biosimilar Annual Revenue by Geographic Region

4.2 World Historic Remicade Biosimilar Market Size by Country/Region (2017-2022)

4.2.1 Global Remicade Biosimilar Annual Sales by Country/Region (2017-2022)

4.2.2 Global Remicade Biosimilar Annual Revenue by Country/Region

4.3 Americas Remicade Biosimilar Sales Growth

4.4 APAC Remicade Biosimilar Sales Growth

4.5 Europe Remicade Biosimilar Sales Growth

4.6 Middle East & Africa Remicade Biosimilar Sales Growth

5 Americas

5.1 Americas Remicade Biosimilar Sales by Country

5.1.1 Americas Remicade Biosimilar Sales by Country (2017-2022)

5.1.2 Americas Remicade Biosimilar Revenue by Country (2017-2022)

5.2 Americas Remicade Biosimilar Sales by Type

5.3 Americas Remicade Biosimilar Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Remicade Biosimilar Sales by Region

6.1.1 APAC Remicade Biosimilar Sales by Region (2017-2022)

6.1.2 APAC Remicade Biosimilar Revenue by Region (2017-2022)

6.2 APAC Remicade Biosimilar Sales by Type

6.3 APAC Remicade Biosimilar Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Remicade Biosimilar by Country

7.1.1 Europe Remicade Biosimilar Sales by Country (2017-2022)

7.1.2 Europe Remicade Biosimilar Revenue by Country (2017-2022)

7.2 Europe Remicade Biosimilar Sales by Type

7.3 Europe Remicade Biosimilar Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Remicade Biosimilar by Country

8.1.1 Middle East & Africa Remicade Biosimilar Sales by Country (2017-2022)

8.1.2 Middle East & Africa Remicade Biosimilar Revenue by Country (2017-2022)

8.2 Middle East & Africa Remicade Biosimilar Sales by Type

8.3 Middle East & Africa Remicade Biosimilar Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Remicade Biosimilar

10.3 Manufacturing Process Analysis of Remicade Biosimilar

10.4 Industry Chain Structure of Remicade Biosimilar

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Remicade Biosimilar Distributors

11.3 Remicade Biosimilar Customer

12 World Forecast Review for Remicade Biosimilar by Geographic Region

12.1 Global Remicade Biosimilar Market Size Forecast by Region

12.1.1 Global Remicade Biosimilar Forecast by Region (2023-2028)

12.1.2 Global Remicade Biosimilar Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Remicade Biosimilar Forecast by Type

12.7 Global Remicade Biosimilar Forecast by Application

13 Key Players Analysis

13.1 Synthon Pharmaceuticals

13.1.1 Synthon Pharmaceuticals Company Information

13.1.2 Synthon Pharmaceuticals Remicade Biosimilar Product Offered

13.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Synthon Pharmaceuticals Main Business Overview

13.1.5 Synthon Pharmaceuticals Latest Developments

13.2 LG Life Sciences

13.2.1 LG Life Sciences Company Information

13.2.2 LG Life Sciences Remicade Biosimilar Product Offered

13.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 LG Life Sciences Main Business Overview

13.2.5 LG Life Sciences Latest Developments

13.3 Novartis (Sandoz)

13.3.1 Novartis (Sandoz) Company Information

13.3.2 Novartis (Sandoz) Remicade Biosimilar Product Offered

13.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis (Sandoz) Main Business Overview

13.3.5 Novartis (Sandoz) Latest Developments

13.4 Celltrion

13.4.1 Celltrion Company Information

13.4.2 Celltrion Remicade Biosimilar Product Offered

13.4.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Celltrion Main Business Overview

13.4.5 Celltrion Latest Developments

13.5 Biocon

13.5.1 Biocon Company Information

13.5.2 Biocon Remicade Biosimilar Product Offered

13.5.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biocon Main Business Overview

13.5.5 Biocon Latest Developments

13.6 Hospira

13.6.1 Hospira Company Information

13.6.2 Hospira Remicade Biosimilar Product Offered

13.6.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hospira Main Business Overview

13.6.5 Hospira Latest Developments

13.7 Merck Serono (Merck Group)

13.7.1 Merck Serono (Merck Group) Company Information

13.7.2 Merck Serono (Merck Group) Remicade Biosimilar Product Offered

13.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Serono (Merck Group) Main Business Overview

13.7.5 Merck Serono (Merck Group) Latest Developments

13.8 Biogen idec Inc.

13.8.1 Biogen idec Inc. Company Information

13.8.2 Biogen idec Inc. Remicade Biosimilar Product Offered

13.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biogen idec Inc. Main Business Overview

13.8.5 Biogen idec Inc. Latest Developments

13.9 Genentech (Roche Group)

13.9.1 Genentech (Roche Group) Company Information

13.9.2 Genentech (Roche Group) Remicade Biosimilar Product Offered

13.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Genentech (Roche Group) Main Business Overview

13.9.5 Genentech (Roche Group) Latest Developments

13.10 Fosun Pharmaceutical

13.10.1 Fosun Pharmaceutical Company Information

13.10.2 Fosun Pharmaceutical Remicade Biosimilar Product Offered

13.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Fosun Pharmaceutical Main Business Overview

13.10.5 Fosun Pharmaceutical Latest Developments

13.11 Livzon Pharmaceutical

13.11.1 Livzon Pharmaceutical Company Information

13.11.2 Livzon Pharmaceutical Remicade Biosimilar Product Offered

13.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Livzon Pharmaceutical Main Business Overview

13.11.5 Livzon Pharmaceutical Latest Developments

13.12 Anke Biotechnology

13.12.1 Anke Biotechnology Company Information

13.12.2 Anke Biotechnology Remicade Biosimilar Product Offered

13.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Anke Biotechnology Main Business Overview

13.12.5 Anke Biotechnology Latest Developments

13.13 Hualan Biological Engineering

13.13.1 Hualan Biological Engineering Company Information

13.13.2 Hualan Biological Engineering Remicade Biosimilar Product Offered

13.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hualan Biological Engineering Main Business Overview

13.13.5 Hualan Biological Engineering Latest Developments

13.14 Walvax Biotechnology

13.14.1 Walvax Biotechnology Company Information

13.14.2 Walvax Biotechnology Remicade Biosimilar Product Offered

13.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Walvax Biotechnology Main Business Overview

13.14.5 Walvax Biotechnology Latest Developments

13.15 Hisun Pharmaceutical

13.15.1 Hisun Pharmaceutical Company Information

13.15.2 Hisun Pharmaceutical Remicade Biosimilar Product Offered

13.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hisun Pharmaceutical Main Business Overview

13.15.5 Hisun Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Remicade Biosimilar Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Remicade Biosimilar Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100mg/10ml

Table 4. Major Players of 500mg/50ml

Table 5. Global Remicade Biosimilar Sales by Type (2017-2022) & (K Units)

Table 6. Global Remicade Biosimilar Sales Market Share by Type (2017-2022)

Table 7. Global Remicade Biosimilar Revenue by Type (2017-2022) & ($ million)

Table 8. Global Remicade Biosimilar Revenue Market Share by Type (2017-2022)

Table 9. Global Remicade Biosimilar Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Remicade Biosimilar Sales by Application (2017-2022) & (K Units)

Table 11. Global Remicade Biosimilar Sales Market Share by Application (2017-2022)

Table 12. Global Remicade Biosimilar Revenue by Application (2017-2022)

Table 13. Global Remicade Biosimilar Revenue Market Share by Application (2017-2022)

Table 14. Global Remicade Biosimilar Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Remicade Biosimilar Sales by Company (2020-2022) & (K Units)

Table 16. Global Remicade Biosimilar Sales Market Share by Company (2020-2022)

Table 17. Global Remicade Biosimilar Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Remicade Biosimilar Revenue Market Share by Company (2020-2022)

Table 19. Global Remicade Biosimilar Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Remicade Biosimilar Producing Area Distribution and Sales Area

Table 21. Players Remicade Biosimilar Products Offered

Table 22. Remicade Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Remicade Biosimilar Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Remicade Biosimilar Sales Market Share Geographic Region (2017-2022)

Table 27. Global Remicade Biosimilar Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Remicade Biosimilar Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Remicade Biosimilar Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Remicade Biosimilar Sales Market Share by Country/Region (2017-2022)

Table 31. Global Remicade Biosimilar Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Remicade Biosimilar Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Remicade Biosimilar Sales by Country (2017-2022) & (K Units)

Table 34. Americas Remicade Biosimilar Sales Market Share by Country (2017-2022)

Table 35. Americas Remicade Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Remicade Biosimilar Revenue Market Share by Country (2017-2022)

Table 37. Americas Remicade Biosimilar Sales by Type (2017-2022) & (K Units)

Table 38. Americas Remicade Biosimilar Sales Market Share by Type (2017-2022)

Table 39. Americas Remicade Biosimilar Sales by Application (2017-2022) & (K Units)

Table 40. Americas Remicade Biosimilar Sales Market Share by Application (2017-2022)

Table 41. APAC Remicade Biosimilar Sales by Region (2017-2022) & (K Units)

Table 42. APAC Remicade Biosimilar Sales Market Share by Region (2017-2022)

Table 43. APAC Remicade Biosimilar Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Remicade Biosimilar Revenue Market Share by Region (2017-2022)

Table 45. APAC Remicade Biosimilar Sales by Type (2017-2022) & (K Units)

Table 46. APAC Remicade Biosimilar Sales Market Share by Type (2017-2022)

Table 47. APAC Remicade Biosimilar Sales by Application (2017-2022) & (K Units)

Table 48. APAC Remicade Biosimilar Sales Market Share by Application (2017-2022)

Table 49. Europe Remicade Biosimilar Sales by Country (2017-2022) & (K Units)

Table 50. Europe Remicade Biosimilar Sales Market Share by Country (2017-2022)

Table 51. Europe Remicade Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Remicade Biosimilar Revenue Market Share by Country (2017-2022)

Table 53. Europe Remicade Biosimilar Sales by Type (2017-2022) & (K Units)

Table 54. Europe Remicade Biosimilar Sales Market Share by Type (2017-2022)

Table 55. Europe Remicade Biosimilar Sales by Application (2017-2022) & (K Units)

Table 56. Europe Remicade Biosimilar Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Remicade Biosimilar Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Remicade Biosimilar Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Remicade Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Remicade Biosimilar Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Remicade Biosimilar Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Remicade Biosimilar Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Remicade Biosimilar Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Remicade Biosimilar

Table 66. Key Market Challenges & Risks of Remicade Biosimilar

Table 67. Key Industry Trends of Remicade Biosimilar

Table 68. Remicade Biosimilar Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Remicade Biosimilar Distributors List

Table 71. Remicade Biosimilar Customer List

Table 72. Global Remicade Biosimilar Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Remicade Biosimilar Sales Market Forecast by Region

Table 74. Global Remicade Biosimilar Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Remicade Biosimilar Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Remicade Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Remicade Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Remicade Biosimilar Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Remicade Biosimilar Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Remicade Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Remicade Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Remicade Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Remicade Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Remicade Biosimilar Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Remicade Biosimilar Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Remicade Biosimilar Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Remicade Biosimilar Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Remicade Biosimilar Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Remicade Biosimilar Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Remicade Biosimilar Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Remicade Biosimilar Revenue Market Share Forecast by Application (2023-2028)

Table 92. Synthon Pharmaceuticals Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 93. Synthon Pharmaceuticals Remicade Biosimilar Product Offered

Table 94. Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Synthon Pharmaceuticals Main Business

Table 96. Synthon Pharmaceuticals Latest Developments

Table 97. LG Life Sciences Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 98. LG Life Sciences Remicade Biosimilar Product Offered

Table 99. LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. LG Life Sciences Main Business

Table 101. LG Life Sciences Latest Developments

Table 102. Novartis (Sandoz) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 103. Novartis (Sandoz) Remicade Biosimilar Product Offered

Table 104. Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Novartis (Sandoz) Main Business

Table 106. Novartis (Sandoz) Latest Developments

Table 107. Celltrion Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 108. Celltrion Remicade Biosimilar Product Offered

Table 109. Celltrion Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Celltrion Main Business

Table 111. Celltrion Latest Developments

Table 112. Biocon Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 113. Biocon Remicade Biosimilar Product Offered

Table 114. Biocon Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Biocon Main Business

Table 116. Biocon Latest Developments

Table 117. Hospira Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 118. Hospira Remicade Biosimilar Product Offered

Table 119. Hospira Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Hospira Main Business

Table 121. Hospira Latest Developments

Table 122. Merck Serono (Merck Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 123. Merck Serono (Merck Group) Remicade Biosimilar Product Offered

Table 124. Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Merck Serono (Merck Group) Main Business

Table 126. Merck Serono (Merck Group) Latest Developments

Table 127. Biogen idec Inc. Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 128. Biogen idec Inc. Remicade Biosimilar Product Offered

Table 129. Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Biogen idec Inc. Main Business

Table 131. Biogen idec Inc. Latest Developments

Table 132. Genentech (Roche Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 133. Genentech (Roche Group) Remicade Biosimilar Product Offered

Table 134. Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Genentech (Roche Group) Main Business

Table 136. Genentech (Roche Group) Latest Developments

Table 137. Fosun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 138. Fosun Pharmaceutical Remicade Biosimilar Product Offered

Table 139. Fosun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Fosun Pharmaceutical Main Business

Table 141. Fosun Pharmaceutical Latest Developments

Table 142. Livzon Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 143. Livzon Pharmaceutical Remicade Biosimilar Product Offered

Table 144. Livzon Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Livzon Pharmaceutical Main Business

Table 146. Livzon Pharmaceutical Latest Developments

Table 147. Anke Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 148. Anke Biotechnology Remicade Biosimilar Product Offered

Table 149. Anke Biotechnology Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Anke Biotechnology Main Business

Table 151. Anke Biotechnology Latest Developments

Table 152. Hualan Biological Engineering Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 153. Hualan Biological Engineering Remicade Biosimilar Product Offered

Table 154. Hualan Biological Engineering Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Hualan Biological Engineering Main Business

Table 156. Hualan Biological Engineering Latest Developments

Table 157. Walvax Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 158. Walvax Biotechnology Remicade Biosimilar Product Offered

Table 159. Walvax Biotechnology Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Walvax Biotechnology Main Business

Table 161. Walvax Biotechnology Latest Developments

Table 162. Hisun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 163. Hisun Pharmaceutical Remicade Biosimilar Product Offered

Table 164. Hisun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Hisun Pharmaceutical Main Business

Table 166. Hisun Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Remicade Biosimilar

Figure 2. Remicade Biosimilar Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Remicade Biosimilar Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Remicade Biosimilar Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Remicade Biosimilar Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100mg/10ml

Figure 10. Product Picture of 500mg/50ml

Figure 11. Global Remicade Biosimilar Sales Market Share by Type in 2021

Figure 12. Global Remicade Biosimilar Revenue Market Share by Type (2017-2022)

Figure 13. Remicade Biosimilar Consumed in Blood Disorders

Figure 14. Global Remicade Biosimilar Market: Blood Disorders (2017-2022) & (K Units)

Figure 15. Remicade Biosimilar Consumed in Oncology Diseases

Figure 16. Global Remicade Biosimilar Market: Oncology Diseases (2017-2022) & (K Units)

Figure 17. Global Remicade Biosimilar Sales Market Share by Application (2017-2022)

Figure 18. Global Remicade Biosimilar Revenue Market Share by Application in 2021

Figure 19. Remicade Biosimilar Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Remicade Biosimilar Revenue Market Share by Company in 2021

Figure 21. Global Remicade Biosimilar Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Remicade Biosimilar Revenue Market Share by Geographic Region in 2021

Figure 23. Global Remicade Biosimilar Sales Market Share by Region (2017-2022)

Figure 24. Global Remicade Biosimilar Revenue Market Share by Country/Region in 2021

Figure 25. Americas Remicade Biosimilar Sales 2017-2022 (K Units)

Figure 26. Americas Remicade Biosimilar Revenue 2017-2022 ($ Millions)

Figure 27. APAC Remicade Biosimilar Sales 2017-2022 (K Units)

Figure 28. APAC Remicade Biosimilar Revenue 2017-2022 ($ Millions)

Figure 29. Europe Remicade Biosimilar Sales 2017-2022 (K Units)

Figure 30. Europe Remicade Biosimilar Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Remicade Biosimilar Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Remicade Biosimilar Revenue 2017-2022 ($ Millions)

Figure 33. Americas Remicade Biosimilar Sales Market Share by Country in 2021

Figure 34. Americas Remicade Biosimilar Revenue Market Share by Country in 2021

Figure 35. United States Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Remicade Biosimilar Sales Market Share by Region in 2021

Figure 40. APAC Remicade Biosimilar Revenue Market Share by Regions in 2021

Figure 41. China Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Remicade Biosimilar Sales Market Share by Country in 2021

Figure 48. Europe Remicade Biosimilar Revenue Market Share by Country in 2021

Figure 49. Germany Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Remicade Biosimilar Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country in 2021

Figure 56. Egypt Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Remicade Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Remicade Biosimilar in 2021

Figure 62. Manufacturing Process Analysis of Remicade Biosimilar

Figure 63. Industry Chain Structure of Remicade Biosimilar

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles